James J. Collins - Jun 17, 2024 Form 4 Insider Report for Fulcrum Therapeutics, Inc. (FULC)

Role
Director
Signature
/s/ Greg Tourangeau, as attorney-in-fact for James J. Collins
Stock symbol
FULC
Transactions as of
Jun 17, 2024
Transactions value $
$0
Form type
4
Date filed
6/18/2024, 04:20 PM
Previous filing
Jun 29, 2023
Next filing
Jul 12, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FULC Stock Option (right to buy) Award $0 +30K $0.00 30K Jun 17, 2024 Common Stock 30K $7.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on June 17, 2024 and is scheduled to vest with respect to all shares on the first anniversary of the grant date or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date, subject to continued service.